Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00093080
Brief Title: Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)

First Submitted : September 30, 2004
First Submitted that Met QC Criteria : October 1, 2004
First Posted : October 4, 2004 (Estimate)

Last Update Submitted that Met QC Criteria : February 12, 2015
Last Update Posted : February 13, 2015 (Estimate)